SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-012811 to COLLECTIVE ACQUISITION CORP. (IPOD)

COLLECTIVE ACQUISITION CORP.
Date: Nov. 19, 2024 · CIK: 0002041047 · Accession: 0000000000-24-012811

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
November 19, 2024
Author
Not clearly detected
Form
UPLOAD
Company
COLLECTIVE ACQUISITION CORP.

Letter

November 19, 2024 Carter Glatt Chief Executive Officer, Director and Chairman Dune Acquisition Corporation II 700 S. Rosemary Avenue, Suite 204 West Palm Beach, FL 33401 Re:Dune Acquisition Corporation II Draft Registration Statement on Form S-1 Submitted October 23, 2024 CIK No. 0002041047 Dear Carter Glatt: We have reviewed your draft registration statement and have the following comments. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this letter and your amended draft registration statement or filed registration statement, we may have additional comments. Draft Registration Statement on Form S-1 submitted October 23, 2024 General 1.Regarding your disclosure of the expressions of interest by the non-managing sponsor investors to indirectly purchase private placement warrants by purchasing sponsor membership units, please revise to add clarifying disclosure to directly compare the percentage of such private warrants that may be purchased to the percentage of private warrants to be held by the sponsor following the offering (and, as applicable, after taking into effect the purchase of membership interests in your sponsor by the independent directors, as you disclose on page 2). Please also revise to disclose the nominal purchase price to be paid by them for the founder shares. Where you discuss the non-managing sponsor investors' expression of interest, please revise to clarify whether their potential purchase of units in the offering is 2.

November 19, 2024 Page 2 conditioned on their potential indirect purchase of private placement warrants and founder shares in a private placement, or vice versa. In this regard, we note your disclosure that the non-managing sponsor investors will potentially have different interests than your other public shareholders in approving your initial business combination and otherwise exercising their rights as public shareholders because of their indirect ownership of founder shares. 3.As applicable, please revise to describe the experience of Mr. Castaldy in organizing special purpose acquisition companies and the extent to which he is involved in other special purpose acquisition companies. In this regard, we note your statement on page 7 and elsewhere that Mr. Castaldy structured numerous SPAC IPOs and business combinations. See Item 1603(a)(3) of Regulation S-K. Cover Page 4.Please state whether the redemptions will be subject to any limitations, such as for shareholders holding 20% or more of the shares sold in the offering. See Item 1602(a)(2) of Regulation S-K. Also disclose the "certain conditions as further described herein" relating to the redemptions or provide a cross-reference to the detailed disclosure in the prospectus. 5.Please expand your discussion of the non-managing sponsor investors to disclose the different interests they may have. In this regard, we note your statement on page 68 that they will potentially have different interests. Please also revise to clarify the maximum percentage of the offering, in the aggregate, that could be purchased by these investors. 6.Please revise to describe in more detail the "permitted withdrawals" from the trust account. Summary, page 1 7.Please revise to describe any plans to seek additional financings and how the terms of additional financings may impact unaffiliated security holders, as required by Item 1602(b)(5) of Regulation S-K. In this regard, we note your disclosures that you intend to effectuate your initial business combination using cash from, among other sources, the proceeds of the sale of your shares pursuant to forward purchase agreements or backstop agreements, that you may raise funds through the issuance of equity-linked securities or through loans, and that you intend to target an initial business combination with enterprise values that are greater than you could acquire with the net proceeds of this offering and the sale of the private placement warrants. 8.Please revise here, and elsewhere as appropriate, to more fully discuss the non- managing sponsor investors' expressions of interest. In this regard, we note your cross-reference on the cover page to a discussion of certain additional arrangements with the non-managing sponsor investors in the Summary section. However, we are unable to locate such discussion. Our Sponsor, page 2 We refer to your page 6 disclosure regarding transfers of equity interests in the sponsor or its direct or indirect parent entities. Please revise to clarify, as you suggest 9.

November 19, 2024 Page 3 on pages 23 and 159-160, whether transfers of equity interests in the sponsor or its direct or indirect parent entities are subject to the transfer restrictions included in the letter agreement. Our Management and Board of Directors, page 7 10.Where you discuss the business combination Dune I consummated with Global Gas, please expand to briefly describe the material terms of the transaction. Ability to extend time to complete business combination, page 28 11.Please expand to disclose whether there are any limitations on extensions of time to complete an initial business combination, including the number of times you may seek to extend. See Item 1602(b)(4) of Regulation S-K. Summary of Risk Factors, page 46 12.Please expand your summary risk factors to highlight the risks related to the ownership by the non-managing sponsor investors and the resulting consequences, as you explain on page 84. Risk Factors We may issue additional Class A ordinary shares or preference shares . . ., page 64 13.We note your disclosure that you may issue additional ordinary or preference shares to complete your initial business combination. Please expand your disclosures to clearly disclose the impact to you and investors, including that the arrangements result in costs particular to the de-SPAC process that would not be anticipated in a traditional IPO. If true, disclose that the agreements are intended to ensure a return on investment to the investor in return for funds facilitating the sponsor’s completion of the business combination or providing sufficient liquidity. Risks Relating to Our Management Team, page 81 14.We note the disclosure on page 6 and elsewhere that in order to facilitate your initial business combination or for any other reason determined by your sponsor in its sole discretion, your sponsor may surrender or forfeit, transfer or exchange your founder shares, private placement warrants or any of your other securities, including for no consideration, or otherwise amend the terms of any such securities or enter into any other arrangements with respect to any such securities. Please add risk factor disclosure about risks that may arise from the sponsor having the ability to remove itself as your sponsor before identifying a business combination, including through the unconditional ability to transfer the founder shares or otherwise. Address the consequences of such removal to the company's ability to consummate an initial business combination, including that any replacement sponsor could have difficulty finding a target. Management, page 148 Please revise to ensure you have disclosed the business experience during the past five years of each director, executive officer, and each person nominated or chosen to become a director. For instance, please ensure you have described the experience for 15.

November 19, 2024 Page 4 each individual for the past five years. See Item 401(e) of Regulation S-K. Principal Shareholders, page 158 16.Please revise the narrative disclosure preceding the table to disclose the percentage of your public units that may be purchased by the non-managing sponsor investors. Please contact Jeffrey Lewis at 202-551-6216 or Mark Rakip at 202-551-3573 if you have questions regarding comments on the financial statements and related matters. Please contact Benjamin Holt at 202-551-6614 or David Link at 202-551-3356 with any other questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction cc:Ari Edelman, Esq.

Show Raw Text
November 19, 2024
Carter Glatt
Chief Executive Officer, Director and Chairman
Dune Acquisition Corporation II
700 S. Rosemary Avenue, Suite 204
West Palm Beach, FL 33401
Re:Dune Acquisition Corporation II
Draft Registration Statement on Form S-1
Submitted October 23, 2024
CIK No. 0002041047
Dear Carter Glatt:
            We have reviewed your draft registration statement and have the following comments.
            Please respond to this letter by providing the requested information and either
submitting an amended draft registration statement or publicly filing your registration
statement on EDGAR. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing the information you provide in response to this letter and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement on Form S-1 submitted October 23, 2024
General
1.Regarding your disclosure of the expressions of interest by the non-managing
sponsor investors to indirectly purchase private placement warrants by purchasing
sponsor membership units, please revise to add clarifying disclosure to directly
compare the percentage of such private warrants that may be purchased to the
percentage of private warrants to be held by the sponsor following the offering (and,
as applicable, after taking into effect the purchase of membership interests in your
sponsor by the independent directors, as you disclose on page 2). Please also revise to
disclose the nominal purchase price to be paid by them for the founder shares.
Where you discuss the non-managing sponsor investors' expression of interest,
please revise to clarify whether their potential purchase of units in the offering is 2.

November 19, 2024
Page 2
conditioned on their potential indirect purchase of private placement warrants and
founder shares in a private placement, or vice versa. In this regard, we note your
disclosure that the non-managing sponsor investors will potentially have different
interests than your other public shareholders in approving your initial business
combination and otherwise exercising their rights as public shareholders because of
their indirect ownership of founder shares.
3.As applicable, please revise to describe the experience of Mr. Castaldy in organizing
special purpose acquisition companies and the extent to which he is involved in other
special purpose acquisition companies. In this regard, we note your statement on page
7 and elsewhere that Mr. Castaldy structured numerous SPAC IPOs and business
combinations. See Item 1603(a)(3) of Regulation S-K.
Cover Page
4.Please state whether the redemptions will be subject to any limitations, such as for
shareholders holding 20% or more of the shares sold in the offering. See Item
1602(a)(2) of Regulation S-K. Also disclose the "certain conditions as further
described herein" relating to the redemptions or provide a cross-reference to the
detailed disclosure in the prospectus.
5.Please expand your discussion of the non-managing sponsor investors to disclose
the different interests they may have. In this regard, we note your statement on page
68 that they will potentially have different interests. Please also revise to clarify the
maximum percentage of the offering, in the aggregate, that could be purchased by
these investors.
6.Please revise to describe in more detail the "permitted withdrawals" from the trust
account.
Summary, page 1
7.Please revise to describe any plans to seek additional financings and how the terms of
additional financings may impact unaffiliated security holders, as required by Item
1602(b)(5) of Regulation S-K. In this regard, we note your disclosures that you intend
to effectuate your initial business combination using cash from, among other sources,
the proceeds of the sale of your shares pursuant to forward purchase agreements or
backstop agreements, that you may raise funds through the issuance of equity-linked
securities or through loans, and that you intend to target an initial business
combination with enterprise values that are greater than you could acquire with the net
proceeds of this offering and the sale of the private placement warrants.
8.Please revise here, and elsewhere as appropriate, to more fully discuss the non-
managing sponsor investors' expressions of interest. In this regard, we note your
cross-reference on the cover page to a discussion of certain additional arrangements
with the non-managing sponsor investors in the Summary section. However, we are
unable to locate such discussion.
Our Sponsor, page 2
We refer to your page 6 disclosure regarding transfers of equity interests in the
sponsor or its direct or indirect parent entities. Please revise to clarify, as you suggest 9.

November 19, 2024
Page 3
on pages 23 and 159-160, whether transfers of equity interests in the sponsor or its
direct or indirect parent entities are subject to the transfer restrictions included in the
letter agreement.
Our Management and Board of Directors, page 7
10.Where you discuss the business combination Dune I consummated with Global Gas,
please expand to briefly describe the material terms of the transaction.
Ability to extend time to complete business combination, page 28
11.Please expand to disclose whether there are any limitations on extensions of time
to complete an initial business combination, including the number of times you may
seek to extend. See Item 1602(b)(4) of Regulation S-K.
Summary of Risk Factors, page 46
12.Please expand your summary risk factors to highlight the risks related to the
ownership by the non-managing sponsor investors and the resulting consequences, as
you explain on page 84.
Risk Factors
We may issue additional Class A ordinary shares or preference shares . . ., page 64
13.We note your disclosure that you may issue additional ordinary or preference shares
to complete your initial business combination. Please expand your disclosures to
clearly disclose the impact to you and investors, including that the arrangements result
in costs particular to the de-SPAC process that would not be anticipated in a
traditional IPO. If true, disclose that the agreements are intended to ensure a return on
investment to the investor in return for funds facilitating the sponsor’s completion of
the business combination or providing sufficient liquidity.
Risks Relating to Our Management Team, page 81
14.We note the disclosure on page 6 and elsewhere that in order to facilitate your
initial business combination or for any other reason determined by your sponsor in its
sole discretion, your sponsor may surrender or forfeit, transfer or exchange your
founder shares, private placement warrants or any of your other securities, including
for no consideration, or otherwise amend the terms of any such securities or enter into
any other arrangements with respect to any such securities. Please add risk factor
disclosure about risks that may arise from the sponsor having the ability to remove
itself as your sponsor before identifying a business combination, including through the
unconditional ability to transfer the founder shares or otherwise. Address the
consequences of such removal to the company's ability to consummate an initial
business combination, including that any replacement sponsor could have difficulty
finding a target.
Management, page 148
Please revise to ensure you have disclosed the business experience during the past
five years of each director, executive officer, and each person nominated or chosen to
become a director. For instance, please ensure you have described the experience for 15.

November 19, 2024
Page 4
each individual for the past five years. See Item 401(e) of Regulation S-K.
Principal Shareholders, page 158
16.Please revise the narrative disclosure preceding the table to disclose the percentage of
your public units that may be purchased by the non-managing sponsor investors.
            Please contact Jeffrey Lewis at 202-551-6216 or Mark Rakip at 202-551-3573 if you
have questions regarding comments on the financial statements and related matters. Please
contact Benjamin Holt at 202-551-6614 or David Link at 202-551-3356 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction
cc:Ari Edelman, Esq.